{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:52:34Z","timestamp":1791269554789,"version":"4.1.0"},"reference-count":8,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"DOI":"10.1111\/apt.71039","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:26:26Z","timestamp":1791267986000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Host Innate Immunity Reaches the Clinic\u2014The Laboratory of Genetics and Physiology Protein 2 (\n                    <scp>LGP2<\/scp>\n                    )\n                    <scp>Q425R<\/scp>\n                    Variant and Severity of Chronic Hepatitis Delta"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-837X","authenticated-orcid":false,"given":"Edoardo G.","family":"Giannini","sequence":"first","affiliation":[{"name":"Gastroenterology Unit, Department of Internal Medicine University of Genoa  Genoa Italy"},{"name":"AOM IRCCS Policlinico San Martino  Genoa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pasta","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Department of Internal Medicine University of Genoa  Genoa Italy"},{"name":"AOM IRCCS Policlinico San Martino  Genoa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice Guidelines on Hepatitis Delta Virus","volume":"79","author":"European Association for the Study of the Liver","year":"2023","journal-title":"Journal of Hepatology"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV Genotype and Persistent Viremia Determine Outcome and Treatment Response in Patients With Chronic Hepatitis Delta","volume":"73","author":"Roulot D.","year":"2020","journal-title":"Journal of Hepatology"},{"key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2022.08.041","article-title":"Effect of Variants in LGP2 on MDA5\u2010Mediated Activation of Interferon Response and Suppression of Hepatitis D Virus Replication","volume":"78","author":"Gillich N.","year":"2023","journal-title":"Journal of Hepatology"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70971"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2022.05.023","article-title":"Hepatitis D Virus\u2010Induced Interferon Response and Administered Interferons Control Cell Division\u2010Mediated Virus Spread","volume":"77","author":"Zhang Z.","year":"2022","journal-title":"Journal of Hepatology"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2019.12.028","article-title":"Hepatitis Delta Genotype 5 Is Associated With Favourable Disease Outcome and Better Response to Treatment Compared to Genotype 1","volume":"72","author":"Spaan M.","year":"2020","journal-title":"Journal of Hepatology"},{"key":"e_1_2_7_8_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJMoa2314134","article-title":"Bulevirtide Combined With Pegylated Interferon for Chronic Hepatitis D","volume":"391","author":"Asselah T.","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/liv.15855","article-title":"Characteristics and Outcome of Anti\u2010Hepatitis D Virus Positive Patients With Hepatocellular Carcinoma","volume":"44","author":"Giannini E. G.","year":"2024","journal-title":"Liver International"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.71039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apt.71039","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.71039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:26:28Z","timestamp":1791267988000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.71039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":8,"alternative-id":["10.1111\/apt.71039"],"URL":"https:\/\/doi.org\/10.1111\/apt.71039","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2026-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"apt.71039"}}